(Photo courtesy BASF SE)

BASF ready to snatch seed bargains as rivals sell assets

Ludwigshafen, Germany | Reuters — BASF will consider buying seed assets that rivals are putting on the block to win antitrust approval for tie-ups, saying bargain prices could persuade BASF to overcome its traditional reluctance to expand into the seeds industry. Sources familiar with BASF’s thinking have said that competition regulators looking at potential buyers […] Read more

(CropScience.Bayer.ca)

Syngenta eyes Bayer assets to bolster seed operations

Basel | Reuters — Switzerland’s Syngenta, the crop protection company acquired by ChemChina, has vowed to bulk up its seeds business and join the chase for assets rival Bayer must sell to gain regulatory approval for its takeover of Monsanto. Syngenta, a distant third in the global seeds market behind Monsanto and Dupont, is determined […] Read more


(Bayer.com)

Bayer to sell Liberty brands to get Monsanto deal passed

Frankfurt | Reuters –– Bayer has agreed to sell its Liberty herbicide and LibertyLink-branded seeds businesses to win antitrust approval for its acquisition of Monsanto, it said on Monday. The divestment of the two global brands, a requirement imposed by South Africa’s Competition Commission on Sunday, will account for the bulk of asset sales worth […] Read more

(Dave Bedard photo)

Bayer, Monsanto start asset sale toward merger clearance

Frankfurt | Reuters — German drug and crop chemical maker Bayer and U.S. seeds company Monsanto are launching asset sales worth roughly US$2.5 billion as they seek regulatory clearance for their US$66 billion merger, people close to the matter said. To kick off an auction process, Bayer’s advisors will send out information packages next week […] Read more



(Bayer.com)

Bayer, Monsanto confirm spending plans after meeting Trump

Frankfurt | Reuters –– Bayer and Monsanto said Tuesday they would spend at least half of their agriculture research and development budget in the U.S. over the next six years, following a meeting with U.S. president-elect Donald Trump last week. The two companies, which are awaiting approval of their agreed US$66 billion deal from Trump’s […] Read more


(Dave Bedard photo)

Monsanto swings to profit on South American demand

Chicago | Reuters — U.S. seeds and agrochemicals company Monsanto, in the process of being bought by Germany’s Bayer for US$66 billion, swung to a quarterly profit, helped by higher demand from South America. Sales of soybe2an seeds and traits jumped 37 per cent as more farmers in South America sowed the company’s genetically modified […] Read more



(Dave Bedard photo)

Monsanto shareholders back Bayer deal

Chicago | Reuters –– Shareholders of U.S. seeds and agrochemicals company Monsanto approved the company’s US$66 billion acquisition by Bayer on Tuesday, a deal that still requires regulatory approval to close as expected in late 2017. Increased research and development spending by the combined companies and plans to develop a global seeds and biotechnology hub […] Read more

Foliar symptoms of SDS in a soybean crop. (APSnet.org)

First soy seed treatment cleared against SDS

A Bayer CropScience fungicide is being pressed into service against sudden death syndrome (SDS) in Canadian soybeans. Bayer on Monday launched a new soybean seed treatment dubbed ILeVO, a suspension containing its Group 7 fungicide fluopyram at a rate of 600 grams per litre. ILeVO will be the first soybean seed treatment registered for use […] Read more